scispace - formally typeset
E

Elio Riboli

Researcher at Imperial College London

Publications -  1180
Citations -  127554

Elio Riboli is an academic researcher from Imperial College London. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Cancer. The author has an hindex of 158, co-authored 1136 publications receiving 110499 citations. Previous affiliations of Elio Riboli include Institute of Cancer Research & German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Diabetes mellitus and the risk of abdominal aortic aneurysm: A systematic review and meta-analysis of prospective studies

TL;DR: These results suggest that individuals with diabetes mellitus are at a reduced risk of abdominal aortic aneurysm, however, whether pharmacological agents for Diabetes mellitus explain this observation needs to be clarified in future studies.
Journal ArticleDOI

Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

TL;DR: Greater haemIron intake may be modestly associated with lung cancer risk, and non-haem iron intake was related inversely with Lung cancer risk; however, this association attenuated after adjustment for smoking history.
Journal ArticleDOI

Ovarian Cancer Early Detection by Circulating CA125 in the context of Anti-CA125 Autoantibody Levels: Results from the EPIC cohort

TL;DR: There is the first evidence of potentially synergistic discrimination effects of CA125 and anti‐CA125 antibodies in ovarian early detection, and if these findings are replicated, evaluating CA125 in the context of its antibody may improve ovarian cancer early detection.
Journal ArticleDOI

Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: Results from the european prospective investigation into nutrition and cancer study

Nirmala Bhoo-Pathy, +59 more
TL;DR: Based on an analysis of data from the European Prospective Investigation into Nutrition and Cancer cohort, total coffee, decaffeinated coffee, and tea consumption are not related to the risk of pancreatic cancer.